Phase1 clinical trial evaluates safety and immunogenicity of mRNA rabies vaccine

First proof-of-concept study of a candidate prophylactic mRNA vaccine in healthy adults
First proof-of-concept study of a candidate prophylactic mRNA vaccine in healthy adults